Veridiana Pires de Camargo

5PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical bacteriologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 17, 2025
Assessment of Rare Cancers and Sarcoma Policy and Sarcoma Drug Approvals in Latin America: A Report From the LACOG Sarcoma Group.

Douglas Dias E Silva, Bruna Bianca Lopes David, Veridiana Pires de Camargo

|Oct 24, 2022
A phase 2 study of first-line nivolumab in patients with locally advanced or metastatic cutaneous squamous-cell carcinoma.

Rodrigo R Munhoz, Guilherme Nader-Marta, Veridiana P de Camargo

|Mar 24, 2021
Approaching glioblastoma during COVID-19 pandemic: current recommendations and considerations in Brazil.

Gabriel Novaes de Rezende Batistella, Adrialdo José Santos, Manoel Antonio de Paiva Neto

|Nov 17, 2020
Trends in Melanoma Mortality in Brazil: A Registry-Based Study.

Guilherme Nader Marta, Rodrigo Ramella Munhoz, Monica La Porte Teixeira

|Apr 18, 2019
Systemic dissemination of glioblastoma: literature review.

Juliana Arcangelo Di Vita Carvalho, Caroline Chaul de Lima Barbosa, Olavo Feher

Pageof 1